REFERENCES
- Paustenbach D.J., Leung H.-W. Techniques for Assessing the Health Risks of Dermal Contact with Chemicals in the Environment. Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants, R.G.M. Wang, J.B. Knaak, H.I. Maibach. CRC Press, Boca Raton, FL 1993; 343–386
- Wester R.C., Maibach H.I. Percutaneous Absorption. Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants, R.G.M. Wang, J.B. Knaak, H.I. Maibach. CRC Press, Boca Raton, FL 1993; 63–74
- Kenny, D.V., and Kelly, T.J. Apparatus and Method for Analysis of Exhaled Breath. U.S. Patent 5,042,501 (August, 1991).
- Fiserova-Bergerova V., Pierce J.T., Droz P.O. Dermal Absorption Potential of Industrial Chemicals: Criteria for Skin Notation. Am. J. Ind. Med. 1990; 17: 617–635, [PUBMED], [INFOTRIEVE], [CSA]
- Thrall K.D., Kenny D.V. Evaluation of a Carbon Tetrachloride Physiologically Based Pharmacokinetic Model Using Real-Time Breath-Analysis Monitoring of the Rat. Inhal. Toxicol. 1996; 8: 251–261
- Gordon S.M., Wallace L.A., Pellizzari E.D., O'Neill H.J. Human Breath Measurements in a Clean-Air Chamber to Determine Half-Lives for Volatile Organic Compounds. Atmos. Environ. 1988; 22: 2165–2170, [CROSSREF]
- Raymer J.H., Pellizzari E.D., Thomas K.W., Cooper S.D. Elimination of Volatile Organic Compounds in Breath After Exposure to Occupational and Environmental Microenvironments. J. Exp. Anal. Environ. Epidemiol. 1991; 1: 439–451
- Thomas K.W., Pellizzari E.D., Cooper S.D. A Canister-Based Method for Collection and GC/MS Analysis of Volatile Organic Compounds in Human Breath. J. Anal. Toxicol. 1991; 15: 54–59, [PUBMED], [INFOTRIEVE], [CSA]
- Gordon S.M., Kenny D.V., Kelly T.J. Continuous Real-Time Breath Analysis for the Measurement of Half-Lives of Expired Volatile Organic Compounds. J. Exp. Anal. Environ. Epidem. 1992; Suppl. 1: 41–54
- McDougal J.N., Jepson G.W., Clewell H.J., III, MacNaughton M.G., Andersen M.E. A Physiological Pharmacokinetic Model for Dermal Absorption of Vapors in the Rat. Toxicol. Appl. Pharmacol. 1986; 84: 286–294, [CROSSREF], [CSA]
- Knaak, J.B., Al-Bayati, M.A., and Raabe, O.G. Physiologically Based Pharmacokinetic Modeling to Predict Tissue Dose and Cholinesterase Inhibition in Workers Exposed to Organophosphorus and Carbamate Pesticides. In Health Risk Assessment. Dermal and Inhalation Exposure and Absorption of Toxicants, Wang, R.G.M.; Knaak, J.B.; Maibach, H.I., Eds.; CRC Press: Boca Raton, FL; pp. 3–29.
- McKone T.E. Linking a PBPK Model for Chloroform with Measured Breath Concentrations in Showers: Implications for Dermal Exposure Models. J. Exp. Anal. Environ. Epidemiol. 1993; 3(3)339–365, [CSA]
- Gargas M.L. An Exhaled Breath Chamber System for Assessing Rates of Metabolism and Rates of Gastrointestinal Absorption with Volatile Compounds. J. Am. Coll. Toxicol. 1990; 9(4)447–453, [CSA]
- Jepson G.W., McDougal J.N. Physiologically Based Modeling of Nonsteady State Dermal Absorption of Halogenated Methanes from an Aqueous Solution. Toxicol. Appl. Pharmacol. 1997; 144: 315–324, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Gordon, S.M.; Callahan, P.J.; Kenny, D.V.; Brinkman, M.C.; Wallace, L.A. (1996). U.S. EPA Internal Grant 0608 (L. Wallace, Principal Investigator). Unpublished data.
- Corley R.A., Mendrala A.L., Smith F.A., Staats D.A., Gargas M.L., Conolly R.B., Andersen M.E., Reitz R.H. Development of a Physiologically Based Pharmacokinetic Model for Chloroform. Toxicol. Appl. Pharmacol. 1990; 103: 512–527, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Reitz R.H., McDougal J.N., Himmelstein M.W., Nolan R.J., Schumann A.M. Physiologically Based Pharmacokinetic Modeling with Methyl Chloroform: Implications for Interspecies, High Dose/Low Dose, and Dose–Route Extrapolations. Toxicol. Appl. Pharmacol. 1988; 95: 185–199, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]